Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion

Stock Track
Apr 20

4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.

The sharp rise appears to be driven by multiple positive developments announced just before the trading session. The company received UKCA certification for its Ct:Vq product for clinical use in the United Kingdom, executed a contract with pharmaceutical giant GlaxoSmithKline for lung imaging analytics, and is reportedly being considered for inclusion in the ASX 200 index.

These developments represent significant milestones for 4DMedical, potentially expanding its market reach in the UK, securing a major commercial partnership with GSK, and gaining increased visibility through potential index inclusion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10